Monoclonal Antibodies

What is Monoclonal Antibody Therapy?

Monoclonal antibody (mAb) therapy is a promising form of treatment for COVID-19. People who may qualify for mAb treatment have experienced the onset of mild to moderate COVID-19 symptoms in the past 10 days, have tested positive for COVID-19 in the past 10 days, and are at high risk for developing more serious symptoms. Early studies suggest that mAb treatment can reduce the amount of the virus that causes COVID-19. Having less of the virus in your system means you may not have to be hospitalized. 

Who qualifies? 

Monoclonal antibody treatment is available to individuals who:

  • Are high risk for developing severe COVID-19 and
  • Have a positive COVID-19 test and have not yet been admitted to the hospital and
  • Are 12 years of age or older (and at least 88 pounds)

What is considered high risk?

  • 65 years of age or older
  • Overweight (body mass index over 25)
  • Pregnancy
  • Chronic kidney disease
  • Diabetes (Type 1 and Type 2)
  • Weakened immune system
  • Currently receiving immunosuppressive treatment
  • Cardiovascular disease/hypertension
  • Chronic lung disease
  • Sickle cell disease
  • Neurodevelopmental disorders
  • Medical-related technological dependence

When should you access Monoclonal Antibody Therapy? 

If you fall into any of the categories that qualify, contact your Health Care Provider as soon as possible, don't wait until you are extremely ill, as this treatment works best before you are extremely ill. 

How to access Monoclonal Antibody Therapy?

Contact your primary health care provider, if you don't have access to a health care provider call the Burleson Public Health call center at (682) 312-2780 to schedule a consultation with a member of  public  health staff. 

To learn more about mAb treatment, visit the website